Document is current
Any future updates will be listed below
-
Authors
Schellhorn, Till
Zucknick, Manuela
Askim, Torunn
Munthe-Kaas, Ragnhild
Ihle-Hansen, Hege
Seljeseth, Yngve M.
Knapskog, Anne-Brita
Næss, Halvor
Ellekjær, Hanne
Thingstad, Pernille
Wyller, Torgeir Bruun
Saltvedt, Ingvild
Beyer, Mona K.
- License Information
-
More Information
Article History
Received: 11 February 2021
Accepted: 6 June 2021
First Online: 14 June 2021
Declarations
:
: The study protocol, all procedures performed in this study, and the MRI sub-study have been approved by the regional committees for medical and health research, “Regionale komiteer for medisinsk og helsefaglig forskningsetikk (REK) Nord” (2015/171, 2016/2306), and registered at(NCT02650531). Participation in the study was voluntary. The participants gave their informed written consent before inclusion in accordance with the Declaration of Helsinki. When a person was unable to give their consent, informed written consent for participation was given by a family proxy.
: Not applicable.
: IS was investigator in the drug trial Boehringer-Ingelheim 1346.0023.The other authors declare they have no competing interests.
